Interferon Beta Drugs for Multiple Sclerosis - WebMD
2024年3月6日 — Scientists think these man-made interferon betas lessen the inflammation from your misfiring immune system. Less inflammation means less damage to the myelin sheaths that cover your nerves, and...
Interferons and Multiple Sclerosis: Lessons from 25 Years of …
Since 1981, clinical and real-world observational studies have demonstrated the effectiveness of interferon therapies in reducing relapse rate, disability worsening/progression, and the number of new or newly enlarging lesions in patients with multiple sclerosis (MS).
Interferon-β treatment for multiple sclerosis - PMC - PubMed …
Interferon-β, approved for use in 1993, was the first treatment to modify the course and prognosis of the disease and remains a mainstay of MS treatment. Numerous large-scale clinical trials in early, active patient populations have established the clinical efficacy of interferon-β in reducing relapses and delaying disability progression.
Interferon β for Multiple Sclerosis - PMC - PubMed Central (PMC)
This article summarizes the 25-year-old successful use of IFN-β treatments for MS. In particular, this article reviews the mechanism of action (MOA), clinical efficacy, safety profile, and adherence of IFN-β therapy in MS. MECHANISM OF ACTION …
Interferon - StatPearls - NCBI Bookshelf
2023年7月10日 — Interferons are currently used clinically to treat viral infections such as hepatitis C, cancers including non-Hodgkin’s lymphoma, and autoimmune diseases such as multiple sclerosis. This activity outlines the different types of interferons, namely interferon alpha, beta, …
Interferon beta-1a: Uses, Dosage, Side Effects, Warnings - Drugs.com
6 天之前 — Interferon beta 1-a is a man-made form of interferon that works in the same way, binding to specific receptors on cell surfaces and decreasing the activity of immune cells that attack the myelin sheath, reducing inflammation in the central nervous system, and helping to suppress the autoimmune response that characterizes MS. Interferon beta-1a ...
Interferons in the Treatment of Multiple Sclerosis
2019年10月30日 — Interferon beta (IFNβ) was the first disease-modifying therapy available to treat multiple sclerosis (MS), providing patients with a treatment that resulted in reduced relapse rates and delays in the onset of disability.
Interferons in the Treatment of Multiple Sclerosis: A Clinical
Interferon beta (IFNβ) was the first disease-modifying therapy available to treat multiple sclerosis (MS), providing patients with a treatment that resulted in reduced relapse rates and delays in the onset of disability.
Interferon beta-1a (intramuscular route, subcutaneous route)
2024年1月31日 — Interferon beta-1a injection is used to treat the relapsing forms of multiple sclerosis (MS), including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease.
Interferon Treatment of Multiple Sclerosis - PMC - National …
2011年12月12日 — The U.S. Food and Drug Administration (FDA) has approved three forms of interferon beta for treating MS. Beta interferon (IFN-B) has multiple effects on the immune system, including an increase in suppressor cell activity and stopping antigens that …